Roxane Loses Bid To Block Hetero's Generic Kidney Drug
A New Jersey federal judge on Wednesday gave the red light to Roxane Laboratories Inc.'s bid to block subsidiaries of Hetero Drugs Ltd. from manufacturing and marketing calcium acetate, a generic...To view the full article, register now.
Already a subscriber? Click here to view full article